BMO Capital and Wedbush are the joint bookrunning managers for deal
By Devika Patel
Knoxville, Tenn., March 26 - Applied Genetic Technologies Corp. said it priced its $50 million initial public offering of stock with a $7.5 million greenshoe. The deal was announced Jan. 10.
The company will sell 4,166,667 common shares at $12.00 per share.
BMO Capital Markets and Wedbush PacGrow Life Sciences are the joint bookrunners.
Proceeds will be used for clinical trials and preclinical studies, working capital and other general corporate purposes.
The clinical-stage biotechnology company is based in Alachua, Fla. It intends to list its common stock on the Nasdaq under the symbol "AGTC."
| Issuer: | Applied Genetic Technologies Corp.
|
| Issue: | Common stock
|
| Amount: | $50 million
|
| Greenshoe: | $7.5 million
|
| Shares: | 4,166,667
|
| Price: | $12.00
|
| Warrants: | No
|
| Bookrunners: | BMO Capital Markets and Wedbush PacGrow Life Sciences
|
| Co-managers: | Cantor Fitzgerald & Co. and Roth Capital Partners
|
| Announcement date: | Jan. 10
|
| Pricing date: | March 26
|
| Stock exchange: | Nasdaq: AGTC
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
